通过全系统强化在尼日利亚吉加瓦州综合可持续减少儿童肺炎和传染病(INSPIRING):整群随机对照试验研究方案
该整群随机对照试验于2021年1月至2022年9月在尼日利亚吉加瓦州Kiyawa地方政府区开展,覆盖33个基层政府卫生机构服务片区(集群),随机1:1分配,32个集群纳入效果评估。干预为本地适配的「全系统强化」包,含社区男女小组、伙伴关系质量记分卡及卫生工作者培训指导与基本设备物资提供。主要结局为7天至59月龄儿童死亡率,预计最小可检测效应量为30%。
要点
- 整群随机对照试验评估全系统强化包对7天至59月龄儿童死亡率的影响。
- 33个集群随机1:1分配,32个集群纳入效果评估,采用意向性治疗分析。
- 假设基线死亡率100/1000活产、80%把握度、5%显著性等,最小可检测效应量为30%。
核心结论
- 该研究将提供基于社区的参与式学习与行动、整合卫生系统强化和问责机制在降低儿童死亡率方面的有效性和成本效果的高质量证据。
研究设计与样本
- 整群随机对照试验,整合过程和经济学评估,于2021年1月至2022年9月在尼日利亚吉加瓦州Kiyawa地方政府区开展,估计人口230,000。
- 集群定义为基层政府卫生机构服务片区(n=33),33个集群在公开仪式上按1:1随机分配,32个集群纳入效果评估。
- 干预为本地适配的「全系统强化」包,包含三种循证方法:社区男女小组、伙伴关系定义质量记分卡、卫生工作者培训、指导及提供基本必需设备和物资。
- 主要结局为7天至59月龄儿童死亡率,采用队列设计前瞻性记录死亡率,次要结局通过基线和终线横断面调查测量。
- 分析采用意向性治疗,比较干预组和对照组集群,并针对compound和试验聚类进行调整。
主要发现
- 假设基线死亡率为100/1000活产、4480个compound且每个compound有3名合格儿童、80%把握度、5%显著性、组内相关系数0.007和集群大小变异系数0.74,研究的最小可检测效应量为30%。
关键数值与推荐
- 主要结局:7天至59月龄儿童死亡率。
- 最小可检测效应量30%,基于基线死亡率100/1000活产、4480个compound、每个compound 3名合格儿童、80%把握度、5%显著性、组内相关系数0.007、集群大小变异系数0.74。
临床怎么用
- 原文未据此给出推荐。
局限性
- 在计算样本量时遇到关键挑战,原因是缺乏及时可靠的死亡率数据以及COVID-19大流行影响的不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Child mortality remains unacceptably high, with Northern Nigeria reporting some of the highest rates globally (e.g. 192/1000 live births in Jigawa State). Coverage of key protect and prevent interventions, such as vaccination and clean cooking fuel use, is low. Additionally, knowledge, care-seeking and health system factors are poor. Therefore, a whole systems approach is needed for sustainable reductions in child mortality. METHODS: This is a cluster randomised controlled trial, with integrated process and economic evaluations, conducted from January 2021 to September 2022. The trial will be conducted in Kiyawa Local Government Area, Jigawa State, Nigeria, with an estimated population of 230,000. Clusters are defined as primary government health facility catchment areas (n = 33). The 33 clusters will be randomly allocated (1:1) in a public ceremony, and 32 clusters included in the impact evaluation. The trial will evaluate a locally adapted 'whole systems strengthening' package of three evidence-based methods: community men's and women's groups, Partnership Defined Quality Scorecard and healthcare worker training, mentorship and provision of basic essential equipment and commodities. The primary outcome is mortality of children aged 7 days to 59 months. Mortality will be recorded prospectively using a cohort design, and secondary outcomes measured through baseline and endline cross-sectional surveys. Assuming the following, we will have a minimum detectable effect size of 30%: (a) baseline mortality of 100 per 1000 livebirths, (b) 4480 compounds with 3 eligible children per compound, (c) 80% power, (d) 5% significance, (e) intra-cluster correlation of 0.007 and (f) coefficient of variance of cluster size of 0.74. Analysis will be by intention-to-treat, comparing intervention and control clusters, adjusting for compound and trial clustering. DISCUSSION: This study will provide robust evidence of the effectiveness and cost-effectiveness of community-based participatory learning and action, with integrated health system strengthening and accountability mechanisms, to reduce child mortality. The ethnographic process evaluation will allow for a rich understanding of how the intervention works in this context. However, we encountered a key challenge in calculating the sample size, given the lack of timely and reliable mortality data and the uncertain impacts of the COVID-19 pandemic. TRIAL REGISTRATION: ISRCTN 39213655 . Registered on 11 December 2019.
引用
- King C, Burgess RA, Bakare AA, et al. Integrated Sustainable childhood Pneumonia and Infectious disease Reduction in Nigeria (INSPIRING) through whole system strengthening in Jigawa, Nigeria: study protocol for a cluster randomised controlled trial. Trials. 2022. PMID: 35101109. doi:10.1186/s13063-021-05859-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。